Terms: = Lymphoma AND ER, estrogen receptor AND Prognosis
49 results:
1. Deubiquitinase USP19 modulates apoptotic calcium release and endoplasmic reticulum stress by deubiquitinating BAG6 in triple negative breast cancer.
Zhang X; Chen X; Qian F; Zhu Y; He G; Yang J; Wu X; Zhang H; Yu X; Liu X
Clin Transl Med; 2023 Sep; 13(9):e1398. PubMed ID: 37700495
[TBL] [Abstract] [Full Text] [Related]
2. Analysis of endoplasmic reticulum stress-related gene signature for the prognosis and pattern in diffuse large B cell lymphoma.
Zhang C; Lin Q; Li C; Chen Z; Deng M; Weng H; Zhu X
Sci Rep; 2023 Aug; 13(1):13894. PubMed ID: 37626099
[TBL] [Abstract] [Full Text] [Related]
3. Antitumoral effects of Bortezomib in malignant mesothelioma: evidence of mild endoplasmic reticulum stress in vitro and activation of T cell response in vivo.
Benvenuto M; Angiolini V; Focaccetti C; Nardozi D; Palumbo C; Carrano R; Rufini A; Bei R; Miele MT; Mancini P; Barillari G; Cirone M; Ferretti E; Tundo GR; Mutti L; Masuelli L; Bei R
Biol Direct; 2023 Apr; 18(1):17. PubMed ID: 37069690
[TBL] [Abstract] [Full Text] [Related]
4. Suppression of KSHV lytic replication and primary effusion lymphoma by selective RNF5 inhibition.
Li X; Wang F; Zhang X; Sun Q; Kuang E
PLoS Pathog; 2023 Jan; 19(1):e1011103. PubMed ID: 36656913
[TBL] [Abstract] [Full Text] [Related]
5. Correlation of B-cell lymphoma 2 immunoexpression in invasive carcinoma of breast, no special type with hormone receptor status, proliferation index, and molecular subtypes.
Azmat H; Faridi J; Habib HM; Bugti UJ; Sheikh AK; Riaz SK
J Cancer Res Ther; 2022 Dec; 18(Supplement):S313-S319. PubMed ID: 36510982
[TBL] [Abstract] [Full Text] [Related]
6. Detecting the expression of HRs and BCL2 via IHC can help identify luminal A-like subtypes of triple-positive breast cancers.
Xu Y; Liang Y; Yin G
Clin Transl Oncol; 2023 Apr; 25(4):1024-1032. PubMed ID: 36376700
[TBL] [Abstract] [Full Text] [Related]
7. Identification of the estrogen receptor beta as a possible new tamoxifen-sensitive target in diffuse large B-cell lymphoma.
Langendonk M; de Jong MRW; Smit N; Seiler J; Reitsma B; Ammatuna E; Glaudemans AWJM; van den Berg A; Huls GA; Visser L; van Meerten T
Blood Cancer J; 2022 Mar; 12(3):36. PubMed ID: 35256592
[TBL] [Abstract] [Full Text] [Related]
8. Changes in Ki-67 in Residual Tumor and Outcome of Primary Inflammatory Breast Cancer Treated With Trimodality Therapy.
Song Z; Li C; Zhou D; Liu J; Qian X; Zhang J
Clin Breast Cancer; 2022 Jul; 22(5):e655-e663. PubMed ID: 35248490
[TBL] [Abstract] [Full Text] [Related]
9. The Natural estrogen receptor Beta Agonist Silibinin as a Promising Therapeutic Tool in Diffuse Large B-cell lymphoma.
Ortona E; Locatelli SL; Pagano MT; Ascione B; Careddu G; Dupuis ML; Marconi M; Carlo-Stella C; Malorni W; Matarrese P; Pierdominici M
Anticancer Res; 2022 Feb; 42(2):767-779. PubMed ID: 35093875
[TBL] [Abstract] [Full Text] [Related]
10. The Acetyltransferase KAT5 Inhibitor NU 9056 Promotes Apoptosis and Inhibits JAK2/STAT3 Pathway in Extranodal NK/T Cell lymphoma.
Xu L; Qin Y; Liu M; Jiao J; Tu D; Zhang M; Yan D; Song X; Sun C; Zhu F; Wang X; Sang W; Xu K
Anticancer Agents Med Chem; 2022; 22(8):1530-1540. PubMed ID: 34503423
[TBL] [Abstract] [Full Text] [Related]
11. Role of FUT8 expression in clinicopathology and patient survival for various malignant tumor types: a systematic review and meta-analysis.
Ma M; Han G; Wang Y; Zhao Z; Guan F; Li X
Aging (Albany NY); 2020 Dec; 13(2):2212-2230. PubMed ID: 33323540
[TBL] [Abstract] [Full Text] [Related]
12. Profile and outcome of receptor conversion in breast cancer metastases: a nation-wide multicenter epidemiological study.
Yi ZB; Yu P; Zhang S; Wang WN; Han YQ; Ouyang QC; Yan M; Wang XJ; Hu XC; Jiang ZF; Huang T; Tong ZS; Wang SS; Yin YM; Li H; Yang RX; Yang HW; Teng YE; Sun T; Cai L; Li HY; Chen X; He JJ; Liu XL; Yang SE; Wang JY; Fan JH; Qiao YL; Xu BH
Int J Cancer; 2021 Feb; 148(3):692-701. PubMed ID: 32700765
[TBL] [Abstract] [Full Text] [Related]
13. Activation of PERK-ATF4-CHOP pathway as a novel therapeutic approach for efficient elimination of HTLV-1-infected cells.
Ikebe E; Matsuoka S; Tezuka K; Kuramitsu M; Okuma K; Nakashima M; Kobayashi S; Makiyama J; Yamagishi M; Oyadomari S; Uchimaru K; Hamaguchi I
Blood Adv; 2020 May; 4(9):1845-1858. PubMed ID: 32369565
[TBL] [Abstract] [Full Text] [Related]
14. Good prognosis for follicular lymphoma with estrogen receptor α-positive follicular dendritic cells.
Ohe R; Meng HX; Yamada A; Ye Aung N; Kabasawa T; Tamura Y; Utsunomiya A; Tamazawa N; Kawamura I; Kitaoka T; Suzuki K; Yanagiya R; Toubai T; Ishizawa K; Yamakawa M
Hematol Oncol; 2020 Aug; 38(3):293-300. PubMed ID: 32196124
[TBL] [Abstract] [Full Text] [Related]
15. lncRNA TCL6 correlates with immune cell infiltration and indicates worse survival in breast cancer.
Zhang Y; Li Z; Chen M; Chen H; Zhong Q; Liang L; Li B
Breast Cancer; 2020 Jul; 27(4):573-585. PubMed ID: 31960363
[TBL] [Abstract] [Full Text] [Related]
16. Capsaicin Induces ATF4 Translation with Upregulation of CHOP, GADD34 and PUMA.
Moriguchi M; Watanabe T; Fujimuro M
Biol Pharm Bull; 2019; 42(8):1428-1432. PubMed ID: 31366879
[TBL] [Abstract] [Full Text] [Related]
17. Dachshund 1 is Differentially Expressed Between Male and Female Breast Cancer: A Matched Case-Control Study of Clinical Characteristics and prognosis.
Cui Q; Kong D; Li Z; Ahiable P; Wang K; Wu K; Wu G
Clin Breast Cancer; 2018 Oct; 18(5):e875-e882. PubMed ID: 29478945
[TBL] [Abstract] [Full Text] [Related]
18. Early Relapse for Multiple Myeloma Patients Undergoing Single Autologous Stem Cell Therapy: A Single-center Experience.
Lee H; Duggan P; Chaudhry A; Neri P; Tay J; Rashid-Kolvear F; Bahlis NJ; Jimenez-Zepeda VH
Clin Lymphoma Myeloma Leuk; 2018 Jan; 18(1):e69-e75. PubMed ID: 29158114
[TBL] [Abstract] [Full Text] [Related]
19. estrogen receptor beta expression and prognosis of diffuse large B cell lymphoma.
Faknuam S; Assanasen T; Ruangvejvorachai P; Hanvivadhanakul P; Intragumtornchai T; Rojnuckarin P
Hematology; 2018 May; 23(4):235-241. PubMed ID: 29032728
[TBL] [Abstract] [Full Text] [Related]
20. BCL2 Regulation according to Molecular Subtype of Breast Cancer by Analysis of The Cancer Genome Atlas Database.
Hwang KT; Kim K; Chang JH; Oh S; Kim YA; Lee JY; Jung SH; Choi IS
Cancer Res Treat; 2018 Jul; 50(3):658-669. PubMed ID: 28701032
[TBL] [Abstract] [Full Text] [Related]
[Next]
